HB 2365 requires licensed child care facilities to stock epinephrine auto-injectors, train staff to recognize and respond to severe allergic reactions, and adopt written allergy management policies by July 2028. Facilities must store devices accessibly, provide staff training on use, and notify emergency services when devices are administered. The bill provides liability protection for staff acting in good faith during emergencies and explicitly excludes public schools from coverage. It directly affects child care facilities by standardizing emergency response protocols for life-threatening allergies.
This bill prevents Missouri's Department of Health and Senior Services from denying trauma center status to hospitals based solely on their distance from other trauma centers. It directly affects hospitals seeking or maintaining level I, II, or III trauma center designations by removing distance as a disqualifying factor. The law requires the department to base designations on whether hospitals meet established clinical criteria, including national verification standards, rather than geographic proximity. Hospitals that meet these criteria - verified by national bodies like the American College of Surgeons - will not face denial due to location.
HB 1826 modifies Missouri school policies to allow students with asthma or anaphylaxis to self-administer prescribed epinephrine. The bill requires schools to authorize students to carry and use their own medication if a physician prescribes it, the student demonstrates proper use, a written treatment plan is approved, and parents sign a liability acknowledgment form (excluding negligence claims). Schools must keep emergency medication accessible and maintain required documentation on file. It also permits school nurses to maintain an emergency supply of epinephrine devices for student use during health crises.
HB 1944 regulates how Missouri health insurers pay for anesthesia services and handle claim adjustments. It prohibits insurers from setting time limits on anesthesia payments or excluding all anesthesia time from calculations. The bill bans automated systems (including AI) for reducing payments on claims, requiring human physician reviews instead, and mandates clear documentation of downcoding decisions with 180-day appeal timelines. This directly affects anesthesia providers, insurers, and state health programs like MO HealthNet.
HB 2430, the "End Hospital Institutionalization Act," requires hospitals to immediately notify courts or mental health authorities when medically stable patients - especially children or those with developmental disabilities, mental illness, or substance use disorders - are unnecessarily kept in hospitals ("boarded") without community care arrangements. It mandates juvenile courts to place affected children in appropriate settings within 24 hours of notification, and the mental health department to provide timely case management and treatment in the least restrictive environment for adults. The state must reimburse hospitals for boarding costs after intervention begins, covering either actual costs or MO HealthNet rates, whichever is higher. This bill directly affects hospitals, juvenile courts, and mental health departments by creating a structured process to end prolonged, unjustified hospital stays. The bill is currently in early legislative stages (prefiled and first reading).
SB 1327 requires health insurance plans and pharmacy benefit managers to count all medication costs (when a generic drug isn't available) toward an enrollee's annual out-of-pocket maximum. It prohibits plans from adjusting cost-sharing requirements based on whether assistance programs exist for non-generic drugs. This directly affects individuals enrolled in health benefit plans who take medications without generic alternatives. The law ensures these medication costs fully count toward coverage limits, providing clearer cost transparency for enrollees.
HB 1901 replaces Missouri's outdated indoor air quality laws with a new "Missouri Clean Indoor Air Act" (sections 191.2710-191.2750). The bill prohibits smoking and vaping in most enclosed public areas - including bars, restaurants, and workplaces - while defining specific terms like "bar," "cigar-tobacco bar," and "electronic smoking device" (ESD) to clarify enforcement. It directly affects businesses (employers), employees, and public venues by requiring smoke-free environments, with strict rules for cigar-tobacco bars (e.g., freestanding locations and revenue limits). The law includes penalty provisions for violations and explicitly exempts entryways and certain medical devices.
HB 2309, titled the "End Organ Harvesting Act of 2026," prohibits Missouri health insurance plans and Medicaid programs (including MO HealthNet and Medicaid managed care) from covering organ transplants or post-transplant care under two specific conditions: if the transplant occurs in China, or if the organ was obtained through sale or donation originating in China. The bill directly affects health insurers, patients seeking transplants involving China, and healthcare providers billing these insurers. Key provisions require health carriers to deny coverage for transplants meeting either of these China-related criteria. This is a policy change restricting insurance coverage for specific transplant scenarios, not a procedural measure.
HB 2260 would allow pharmacists to dispense an emergency supply of insulin to patients without a new prescription when a patient's regular insulin supply is unavailable. This change directly affects pharmacists, who would gain this specific authority, and patients facing urgent insulin shortages. The bill creates a new provision (section 338.740) that permits pharmacists to provide this emergency supply under defined conditions. The measure aims to improve immediate access to critical insulin medication during temporary shortages.
SB 1236 requires physicians to disclose to their patients any free products, payments, or other benefits they receive from drug or medical device manufacturers. This directly affects physicians who accept such benefits and their patients during medical consultations. The key mechanism is a mandatory disclosure requirement at the point of care, ensuring patients are informed about potential financial ties. The bill aims to increase transparency in physician-patient relationships regarding manufacturer influences.
